Curtin NJ - Search Results

1

The Philadelphia translocation and pre-existing myeloproliferative disorders.

Curtin NJ, Campbell PJ, Green AR. Curtin NJ, et al. Br J Haematol. 2005 Mar;128(5):734-6. doi: 10.1111/j.1365-2141.2005.05396.x. Br J Haematol. 2005. PMID: 15725099 Free article. No abstract available.

2

Management of the myeloproliferative disorders : distinguishing data from dogma.

Green AR, Vassiliou GS, Curtin N, Campbell PJ. Green AR, et al. Hematol J. 2004;5 Suppl 3:S126-32. doi: 10.1038/sj.thj.6200438. Hematol J. 2004. PMID: 15190294 Review. No abstract available.

3

Pain from myelofibrosis treated with regular pamidronate.

Perkins P, Curtin NJ, Green AR, Booth S. Perkins P, et al. Among authors: curtin nj. Br J Haematol. 2004 Nov;127(3):366-7. doi: 10.1111/j.1365-2141.2004.05213.x. Br J Haematol. 2004. PMID: 15491303 Free article. No abstract available.

4

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR; Cancer Genome Project. Baxter EJ, et al. Lancet. 2005 Mar 19-25;365(9464):1054-61. doi: 10.1016/S0140-6736(05)71142-9. Lancet. 2005. PMID: 15781101

5

Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility.

Curtin NJ, Schwarer AP. Curtin NJ, et al. Clin Lab Haematol. 2005 Jun;27(3):206-8. doi: 10.1111/j.1365-2257.2005.00690.x. Clin Lab Haematol. 2005. PMID: 15938729

6

Delayed haemolytic transfusion reaction due to anti-Jkb in a patient with non-Hodgkin's lymphoma-transient nature of anti-Jkb and the importance of early serological diagnosis.

Hussain SS, Ebbs AM, Curtin NJ, Keidan AJ. Hussain SS, et al. Among authors: curtin nj. Transfus Med. 2007 Jun;17(3):197-9. doi: 10.1111/j.1365-3148.2007.00745.x. Transfus Med. 2007. PMID: 17561862

7

Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series.

Abasszade JH, La PBD, Shelmerdine E, Nalpantidis A, Curtin N, Grigoriadis G, Fedele PL. Abasszade JH, et al. Pathology. 2022 Oct;54(6):802-805. doi: 10.1016/j.pathol.2022.07.002. Epub 2022 Aug 6. Pathology. 2022. PMID: 35989103 Free PMC article. No abstract available.

8

A Systematic Review of the Molecular Mechanisms Involved in the Association Between PCOS and Endometrial and Ovarian Cancers.

Zanjirband M, Nasr-Esfahani MH, Curtin NJ, Drew Y, Sharma Saha S, Adibi P, Lunec J. Zanjirband M, et al. Among authors: curtin nj. J Cell Mol Med. 2024 Dec;28(24):e70312. doi: 10.1111/jcmm.70312. J Cell Mol Med. 2024. PMID: 39720923 Free PMC article. Review.

9

DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications.

Drew Y, Zenke FT, Curtin NJ. Drew Y, et al. Among authors: curtin nj. Nat Rev Drug Discov. 2024 Nov 12. doi: 10.1038/s41573-024-01060-w. Online ahead of print. Nat Rev Drug Discov. 2024. PMID: 39533099 Review.

10

The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.

Papp H, Tóth E, Bóvári-Biri J, Bánfai K, Juhász P, Mahdi M, Russo LC, Bajusz D, Sipos A, Petri L, Szalai TV, Kemény Á, Madai M, Kuczmog A, Batta G, Mózner O, Vaskó D, Hirsch E, Bohus P, Méhes G, Tőzsér J, Curtin NJ, Helyes Z, Tóth A, Hoch NC, Jakab F, Keserű GM, Pongrácz JE, Bai P. Papp H, et al. Among authors: curtin nj. Br J Pharmacol. 2024 Dec;181(23):4782-4803. doi: 10.1111/bph.17305. Epub 2024 Aug 27. Br J Pharmacol. 2024. PMID: 39191429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters